1 Altwegg O, Weisskopf S, Mattmüller M, Spieler P, Grandinetti T, et al. (2020) Akute Blasenentzündung – Behandlung ohne Antibiotika. Prim Hosp Care 20: 23–28.
2 Vik I, Bollestad M, Grude N, Bærheim A, Damsgaard E, et al. (2018) Ibuprofen versus pivmecillinam for uncomplicated urinary tract infection in women - A double-blind, randomized non-inferiority trial. PLoS Med 15: e1002569.
3 Kronenberg A, Bütikofer L, Odutayo A, Mühlemann K, Costa BR da, et al. (2017) Symptomatic treatment of uncomplicated lower urinary tract infections in the ambulatory setting: randomised, double blind trial. BMJ 359: j4784.
4 Gágyor I, Bleidorn J, Kochen MM, Schmiemann G, Wegscheider K, et al. (2015) Ibuprofen versus fosfomycin for uncomplicated urinary tract infection in women: randomised controlled trial. BMJ 351: h6544.
5 Moore M, Trill J, Simpson C, Webley F, Radford M, et al. (2019) Uva-ursi extract and ibuprofen as alternative treatments for uncomplicated urinary tract infection in women (ATAFUTI): a factorial randomized trial. Clin Microbiol Infect 25: 973–980.
6 Sihra N, Goodman A, Zakri R, Sahai A, Malde S (2018) Nonantibiotic prevention and management of recurrent urinary tract infection. Nat Rev Urol 15: 750.
7 Finucane TE (2017) ‘Urinary Tract Infection’ and the Microbiome. Am J Med 130: e97–e98.
8 Finucane TE (2017) “Urinary Tract Infection” – Requiem for a Heavyweight. J Am Geriatr Soc 65: 1650–1655.
9 Lipsky BA (1989) Urinary Tract Infections in Men: Epidemiology, Pathophysiology, Diagnosis, and Treatment. Ann Intern Med 110: 138.
10 Schaeffer AJ, Nicolle LE (2016) Urinary Tract Infections in Older Men. N Engl J Med 374: 562–571.
11 Zanella M-C, Schoofs F, Huttner B, Huttner A (2017) Infections urinaires basses non associées aux sondes urinaires chez l’homme. Urétrite, cystite et prostatite. Rev Médicale Suisse 13: 808–814.
12 Kronenberg A, Koenig S, Droz S, Mühlemann K (2011) Active surveillance of antibiotic resistance prevalence in urinary tract and skin infections in the outpatient setting. Clin Microbiol Infect 17: 1845–1851.
13 Plate A, Kronenberg A, Risch M, Mueller Y, Di Gangi S, et al. (2019) Active surveillance of antibiotic resistance patterns in urinary tract infections in primary care in Switzerland. Infection 47: 1027–1035.
14 Savaria F, Zbinden R, Wüst J, Burnens A, Ledergerber B, et al. (2012) Antibiotikaresistenzen von E.coli in Urinproben: Prävalenzdaten dreier Laboratorien im Raum Zürich von 1985 bis 2010. Praxis 101: 573–579.
15 anresis.ch - Schweizerisches Zentrum für Antibiotikaresistenzen (n.d.). Startseite. Available:
http://anresis.ch/index.php/. Accessed 15 November 2019.
16 Bundesamt für Gesundheit (2019) BAG Bulletin. Informationsmagazin für medizinische Fachpersonen und Medienschaffende: Meldungen ausgewählter multiresistenter Mikroorganismen in der Schweiz. 44/19: 10.
17 Strategie Antibiotikaresistenzen StAR (n.d.). Available:
https://www.star.admin.ch/star/de/home.html. Accessed 15 November 2019.
18 Fulchini R, Albrich WC, Kronenberg A, Egli A, Kahlert CR, et al. (2019) Antibiotic-resistant pathogens in different patient settings and identification of surveillance gaps in Switzerland – a systematic review. Epidemiol Infect 147: e259.
19 Zanichelli V, Huttner A, Harbarth S, Kronenberg A, Huttner B, et al. (2019) Antimicrobial resistance trends in Escherichia coli, Klebsiella pneumoniae and Proteus mirabilis urinary isolates from Switzerland: retrospective analysis of data from a national surveillance network over an 8-year period (2009–2016). Swiss Med Wkly 149: w20110.
20 Foxman B (2013) Editorial Commentary: Extended-Spectrum β-Lactamase–Producing Escherichia coli in the United States: Time to Rethink Empirical Treatment for Suspected E. coli Infections? Clin Infect Dis 56: 649–651.
21 Tarr P, Baumann K, Wallnöfer A, Zimmerli F, Maritz D, et al. (2013) Akute Harnwegsinfektionen, Teil 1: HWI in der Praxis. Swiss Med Forum 13: 467–471.
22 Gharbi M, Drysdale JH, Lishman H, Goudie R, Molokhia M, et al. (2019) Antibiotic management of urinary tract infection in elderly patients in primary care and its association with bloodstream infections and all cause mortality: population based cohort study. BMJ 364: l525.
23 Gupta K, Hooton TM, Naber KG, Wullt B, Colgan R, et al. (2011) International Clinical Practice Guidelines for the Treatment of Acute Uncomplicated Cystitis and Pyelonephritis in Women: A 2010 Update by the Infectious Diseases Society of America and the European Society for Microbiology and Infectious Diseases. Clin Infect Dis 52: e103–e120.
24 Huttner A, Kronenberg A, Hasse B, Galperine TK (2019) Richtlinie: Harnwegsinfekt (HWI). Guidelines Société Suisse d’Infectiologie. Available:
https://ssi.guidelines.ch/guideline/2981. Accessed 13 November 2019.
25 Little P (2017) Antibiotics or NSAIDs for uncomplicated urinary tract infection? BMJ 359: j5037.
26 Betschart C, Albrich W, Brandner S, Faltin D, Kuhn A, et al. (2018) Expertenbrief No 58: Akute und rezidivierende Harnwegsinfektionen. Schweizerische Gesellschaft für Gynäkologie und Geburtshilfe. Available:
https://www.sggg.ch/fileadmin/user_upload/58_Harnwegsinfekt_Juni_2018.pdf. Accessed 11 November 2019.
27 Wilson ML, Gaido L (2004) Laboratory Diagnosis of Urinary Tract Infections in Adult Patients. Clin Infect Dis 38: 1150–1158.
28 Hooton TM (2012) Uncomplicated Urinary Tract Infection. N Engl J Med 366: 1028–1037.
29 Foxman B (2002) Epidemiology of urinary tract infections: incidence, morbidity, and economic costs. Am J Med 113: 5–13.
30 Alleman S (2016) D-Mannose als Prophylaxe bei der unkomplizierten Harnwegsinfektion. Pharm Care Res Group Basel 4: 1-2. Available:
https://imail-offizin.ch/de/article/download/178/D-Mannose-N4-2922016.pdf. Accessed 15 November 2019.
31 Butler CC, Hawking MK, Quigley A, McNulty CA (2015) Incidence, severity, help seeking, and management of uncomplicated urinary tract infection: a population-based survey. Br J Gen Pract 65: e702–e707.
32 Ikäheimo R, Siitonen A, Heiskanen T, Kärkkäinen U, Kuosmanen P, et al. (1996) Recurrence of urinary tract infection in a primary care setting: analysis of a 1-year follow-up of 179 women. Clin Infect Dis 22: 91–99.
33 Foxman B, Barlow R, D’Arcy H, Gillespie B, Sobel JD (2000) Urinary tract infection: self-reported incidence and associated costs. Ann Epidemiol 10: 509–515.
34 Herthelius BM, Hedström K-G, Möllby R, Pettersson L, Winberg J, et al. (1988) Pathogenesis of urinary tract infections – Amoxicillin induces genital escherichia coli colonization. Infection 16: 263–266.
35 Herthelius M, Möllby R, Nord CE, Winberg J (1989) Amoxicillin promotes vaginal colonization with adhering Escherichia coli present in faeces. Pediatr Nephrol 3: 443–447.
36 Cai T, Mazzoli S, Mondaini N, Meacci F, Nesi G, et al. (2012) The role of asymptomatic bacteriuria in young women with recurrent urinary tract infections: to treat or not to treat? Clin Infect Dis 55: 771–777.
37 Schneeberger C, Stolk RP, Devries JH, Schneeberger PM, Herings RM, et al. (2008) Differences in the pattern of antibiotic prescription profile and recurrence rate for possible urinary tract infections in women with and without diabetes. Diabetes Care 31: 1380–1385.
38 Drekonja DM, Okoye NC, Kuskowski MA, Johnson JR (2010) Appropriateness of Urinary Tract Infection Diagnosis and Treatment Duration. Arch Intern Med 170: 489–490.
39 Foxman B, Somsel P, Tallman P, Gillespie B, Raz R, et al. (2001) Urinary tract infection among women aged 40 to 65: behavioral and sexual risk factors. J Clin Epidemiol 54: 710–718.
40 Hilt EE, McKinley K, Pearce MM, Rosenfeld AB, Zilliox MJ, et al. (2014) Urine is not sterile: Use of enhanced urine culture techniques to detect resident bacterial flora in the adult female bladder. J Clin Microbiol 52: 871–876.
41 Brubaker L, Wolfe AJ (2017) Microbiota in 2016: Associating infection and incontinence with the female urinary microbiota. Nat Rev Urol 14: 72–74.
42 Aragón IM, Herrera-Imbroda B, Queipo-Ortuño MI, Castillo E, Del Moral JS-G, et al. (2018) The Urinary Tract Microbiome in Health and Disease. Eur Urol Focus 4: 128–138.
43 Little P, Moore MV, Turner S, Rumsby K, Warner G, et al. (2010) Effectiveness of five different approaches in management of urinary tract infection: randomised controlled trial. BMJ 340: c199.
44 Butler CC, Francis NA, Thomas-Jones E, Longo M, Wootton M, et al. (2018) Point-of-care urine culture for managing urinary tract infection in primary care: a randomised controlled trial of clinical and cost-effectiveness. Br J Gen Pract J R Coll Gen Pract 68: e268–e278.
45 Huttner A, Kowalczyk A, Turjeman A, Babich T, Brossier C, et al. (2018) Effect of 5-Day Nitrofurantoin vs Single-Dose Fosfomycin on Clinical Resolution of Uncomplicated Lower Urinary Tract Infection in Women: A Randomized Clinical Trial. JAMA 319: 1781–1789.
46 Butler CC, Francis N, Thomas-Jones E, Llor C, Bongard E, et al. (2017) Variations in presentation, management, and patient outcomes of urinary tract infection: a prospective four-country primary care observational cohort study. Br J Gen Pract 67: e830–e841.
47 Little P, Merriman R, Turner S, Rumsby K, Warner G, et al. (2010) Presentation, pattern, and natural course of severe symptoms, and role of antibiotics and antibiotic resistance among patients presenting with suspected uncomplicated urinary tract infection in primary care: observational study. BMJ 340: b5633.
48 Heytens S, De Sutter A, Coorevits L, Cools P, Boelens J, et al. (2017) Women with symptoms of a urinary tract infection but a negative urine culture: PCR-based quantification of Escherichia coli suggests infection in most cases. Clin Microbiol Infect 23: 647–652.
49 Scholes D, Hooton TM, Roberts PL, Stapleton AE, Gupta K, et al. (2000) Risk factors for recurrent urinary tract infection in young women. J Infect Dis 182: 1177–1182.
50 Moore E, Hawes S, Scholes D, Boyko E, Hughes J, et al. (2008) Sexual Intercourse and Risk of Symptomatic Urinary Tract Infection in Post-Menopausal Women. J Gen Intern Med 23: 595–599.
51 Little P, Rumsby K, Jones R, Warner G, Moore M, et al. (2010) Validating the prediction of lower urinary tract infection in primary care: sensitivity and specificity of urinary dipsticks and clinical scores in women. Br J Gen Pract 60: 495–500.
52 Barber AE, Norton JP, Spivak AM, Mulvey MA (2013) Urinary Tract Infections: Current and Emerging Management Strategies. Clin Infect Dis 57: 719–724.
53 Raz R, Gennesin Y, Wasser J, Stoler Z, Rosenfeld S, et al. (2000) Recurrent urinary tract infections in postmenopausal women. Clin Infect Dis 30: 152–156.
54 Appa AA, Brown JS, Creasman J, Van Den Eeden SK, Subak LL, et al. (2013) Clinical predictors and significance of postvoid residual volume in women with diabetes. Diabetes Res Clin Pract 101: 164–169.
55 May M, Brookman-Amissah S, Hoschke B, Gilfrich C, Braun K-P, et al. (2009) Post-void residual urine as a predictor of urinary tract infection--is there a cutoff value in asymptomatic men? J Urol 181: 2540–2544.
56 Omli R, Skotnes LH, Mykletun A, Bakke AM, Kuhry E (2008) Residual urine as a risk factor for lower urinary tract infection: a 1-year follow-up study in nursing homes. J Am Geriatr Soc 56: 871–874.
57 Stern JA, Hsieh Y-C, Schaeffer AJ (2004) Residual urine in an elderly female population: novel implications for oral estrogen replacement and impact on recurrent urinary tract infection. J Urol 171: 768–770.
58 Truzzi JCI, Almeida FMR, Nunes EC, Sadi MV (2008) Residual urinary volume and urinary tract infection – when are they linked? J Urol 180: 182–185.
59 Huang AJ, Brown JS, Boyko EJ, Moore EE, Scholes D, et al. (2011) Clinical significance of postvoid residual volume in older ambulatory women. J Am Geriatr Soc 59: 1452–1458.
60 Tarr P, Baumann K, Wallnöfer A, Zimmerli F, Maritz D, et al. (2013) Akute Harnwegsinfektionen, Teil 2: HWI im Spital und Alters- und Pflegeheim. Swiss Med Forum 13: 472–475.
61 Detweiler K, Mayers D, Fletcher SG (2015) Bacteruria and Urinary Tract Infections in the Elderly. Urol Clin 42: 561–568.
62 Mody L, Juthani-Mehta M (2014) Urinary Tract Infections in Older Women: A Clinical Review. JAMA 311: 844–854.
63 Caljouw MA, den Elzen WP, Cools HJ, Gussekloo J (2011) Predictive factors of urinary tract infections among the oldest old in the general population. A population-based prospective follow-up study. BMC Med 9: 57.
64 Hasse B, Huttner A, Huttner B, Egger M, Zanetti G, et al. (2014) Behandlung von unkomplizierten Harnwegsinfektionen. Schweiz Ges Für Infekt. Available:
https://www.sginf.ch/files/behandlung_von_unkomplizierten_harnwegsinfektionen.pdf. Accessed 30 March 2019.
65 Nicolle LE, Bradley S, Colgan R, Rice JC, Schaeffer A, et al. (2005) Infectious Diseases Society of America Guidelines for the Diagnosis and Treatment of Asymptomatic Bacteriuria in Adults. Clin Infect Dis 40: 643–654.
66 Orr PH, Nicolle LE, Duckworth H, Brunka J, Kennedy J, et al. (1996) Febrile urinary infection in the institutionalized elderly. Am J Med 100: 71–77.
67 Datta R, Advani S, Rink A, Bianco L, Van Ness PH, et al. (2018) Frequency of Infection during Fever Episodes among Long-Term Care Residents. J Gerontol Geriatr Res 7: 467.
68 Su S-B, Wang J-N, Lu C-W, Guo H-R (2006) Reducing urinary tract infections among female clean room workers. J Womens Health 15: 870–876.
69 Hooton TM, Vecchio M, Iroz A, Tack I, Dornic Q, et al. (2018) Effect of Increased Daily Water Intake in Premenopausal Women With Recurrent Urinary Tract Infections: A Randomized Clinical Trial. JAMA Intern Med 178: 1509–1515.
70 Smith AL, Stapleton AE, Brown J, Wyman JF, Berry A, et al. (2018) Treatment and Prevention of Recurrent Lower Urinary Tract Infections in Women: A Rapid Review with Practice Recommendations. J Urol 200: 1174–1191.
71 Beerepoot M, Geerlings S (2016) Non-Antibiotic Prophylaxis for Urinary Tract Infections. Pathogens 5: 36.
72 Barbosa-Cesnik C, Brown MB, Buxton M, Zhang L, DeBusscher J, et al. (2011) Cranberry Juice Fails to Prevent Recurrent Urinary Tract Infection: Results From a Randomized Placebo-Controlled Trial. Clin Infect Dis 52: 23–30.
73 Stapleton AE, Au-Yeung M, Hooton TM, Fredricks DN, Roberts PL, et al. (2011) Randomized, Placebo-Controlled Phase 2 Trial of a Lactobacillus crispatus Probiotic Given Intravaginally for Prevention of Recurrent Urinary Tract Infection. Clin Infect Dis 52: 1212–1217.
74 Kranjčec B, Papeš D, Altarac S (2014) D-mannose powder for prophylaxis of recurrent urinary tract infections in women: a randomized clinical trial. World J Urol 32: 79–84.
75 Hopkins WJ, Elkahwaji J, Beierle LM, Leverson GE, Uehling DT (2007) Vaginal mucosal vaccine for recurrent urinary tract infections in women: results of a phase 2 clinical trial. J Urol 177: 1349–1353; quiz 1591.
76 Gilbart J (2011) Recurrent uncomplicated urinary tract infections-the place of immuno-prophylaxis. Eur Urol Rev 6: 114–119.
77 Bauer HW, Alloussi S, Egger G, Blümlein H-M, Cozma G, et al. (2005) A Long-Term, Multicenter, Double-Blind Study of an Escherichia Coli Extract (OM-89) in Female Patients with Recurrent Urinary Tract Infections. Eur Urol 47: 542–548.
78 Wagenlehner FME, Ballarini S, Pilatz A, Weidner W, Lehr L, et al. (2015) A Randomized, Double-Blind, Parallel-Group, Multicenter Clinical Study of Escherichia coli-Lyophilized Lysate for the Prophylaxis of Recurrent Uncomplicated Urinary Tract Infections. Urol Int 95: 167–176.
79 Ravel J, Gajer P, Abdo Z, Schneider GM, Koenig SSK, et al. (2011) Vaginal microbiome of reproductive-age women. Proc Natl Acad Sci U S A 108 Suppl 1: 4680–4687.
80 Diop K, Dufour J-C, Levasseur A, Fenollar F (2019) Exhaustive repertoire of human vaginal microbiota. Hum Microbiome J 11: 100051.
81 Stapleton AE (2016) The Vaginal Microbiota and Urinary Tract Infection. Microbiol Spectr 4.
82 Kontiokari T, Sundqvist K, Nuutinen M, Pokka T, Koskela M, et al. (2001) Randomised trial of cranberry-lingonberry juice and Lactobacillus GG drink for the prevention of urinary tract infections in women. BMJ 322: 1571.
83 Beerepoot MAJ, Riet G ter, Nys S, Wal WM van der, Borgie CAJM de, et al. (2012) Lactobacilli vs Antibiotics to Prevent Urinary Tract Infections: A Randomized, Double-blind, Noninferiority Trial in Postmenopausal Women. Arch Intern Med 172: 704–712.
84 Schwenger EM, Tejani AM, Loewen PS (2015) Probiotics for preventing urinary tract infections in adults and children. Cochrane Database Syst Rev 12. Available: https://www.cochranelibrary.com/cdsr/doi/10.1002/14651858.CD008772.pub2/full. Accessed 30 March 2019.
85 Yelin I, Flett KB, Merakou C, Mehrotra P, Stam J, et al. (2019) Genomic and epidemiological evidence of bacterial transmission from probiotic capsule to blood in ICU patients. Nat Med 25: 1728–1732.
86 Conen A, Zimmerer S, Trampuz A, Frei R, Battegay M, et al. (2009) A pain in the neck: probiotics for ulcerative colitis. Ann Intern Med 151: 895–897.
87 Baerheim A, Larsen E, Digranes A (1994) Vaginal application of lactobacilli in the prophylaxis of recurrent lower urinary tract infection in women. Scand J Prim Health Care 12: 239–243.
88 Czaja CA, Stapleton AE, Yarova-Yarovaya Y, Stamm WE (2007) Phase I Trial of a Lactobacillus crispatus Vaginal Suppository for Prevention of Recurrent Urinary Tract Infection in Women. Infect Dis Obstet Gynecol. Available: https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2216064/. Accessed 30 March 2019.
89 O’Hare PG, Hoffmann AR, Allen P, Gordon BC, Salin L, et al. (2010) Interstitial cystitis patients’ use and rating of complementary and alternative medicine therapies. Int Urogynecology J 24: 977–982.
90 Pang R, Ali A (2015) The Chinese approach to complementary and alternative medicine treatment for interstitial cystitis/bladder pain syndrome. Transl Androl Urol 4: 653–661.
91 Hino K, Honjo H, Nakao M, Kitakoji H (2010) The Effects of Sacral Acupuncture on Acetic Acid-induced Bladder Irritation in Conscious Rats. Urology 75: 730–734.
92 Alraek T, Soedal LIF, Fagerheim SU, Digranes A, Baerheim A (2002) Acupuncture Treatment in the Prevention of Uncomplicated Recurrent Lower Urinary Tract Infections in Adult Women. Am J Public Health 92: 1609–1611.
93 Aune A, Alraek T, LiHua H, Baerheim A (1998) Acupuncture in the prophylaxis of recurrent lower urinary tract infection in adult women. Scand J Prim Health Care 16: 37–39.
94 Sönmez MG, Kozanhan B (2017) Complete response to acupuncture therapy in female patients with refractory interstitial cystitis/bladder pain syndrome. Ginekol Pol 88: 61–67.
95 Lüthje P, Brauner H, Ramos NL, Övregaard A, Gläser R, et al. (2013) Estrogen Supports Urothelial Defense Mechanisms. Sci Transl Med 5: 190ra80.
96 Rahn DD, Carberry C, Sanses TV, Mamik MM, Ward RM, et al. (2014) Vaginal Estrogen for Genitourinary Syndrome of Menopause. Obstet Gynecol 124: 1147–1156.
97 Bonkat G, Bartoletti RR, Bruyère F, Cai T, Geerlings SE, et al. (2016) EAU Guidelines: Urological Infections. Eur Assoc Urol EAU. Available: https://uroweb.org/guideline/urological-infections/. Accessed 13 August 2019.
98 Perrotta C, Aznar M, Mejia R, Albert X, Ng CW (2008) Oestrogens for preventing recurrent urinary tract infection in postmenopausal women. Cochrane Database Syst Rev. Available: https://www.cochranelibrary.com/cdsr/doi/10.1002/14651858.CD005131.pub2/abstract. Accessed 12 August 2019.
99 Schmiemann G, Gebhardt K, Hummers-Pradier E (2018) DEGAM Leitlinien: Brennen beim Wasserlassen. Dtsch Ges Für Allg Fam 1. Available: https://www.awmf.org/leitlinien/detail/ll/053-001.html. Accessed 13 August 2019.
100 Pannek J, Pannek-Rademacher S, Jus MS, Wöllner J, Krebs J (2018) Usefulness of classical homeopathy for the prophylaxis of recurrent urinary tract infections in individuals with chronic neurogenic lower urinary tract dysfunction. J Spinal Cord Med 42: 453–459.
101 van der Werf ET, Duncan LJ, Flotow P von, Baars EW (2018) Do NHS GP surgeries employing GPs additionally trained in integrative or complementary medicine have lower antibiotic prescribing rates? Retrospective cross-sectional analysis of national primary care prescribing data in England in 2016. BMJ Open 8: e020488.
102 Gaertner K, von Ammon K, Frei-Erb M (2020) Individualized Homeopathic Treatment in Women with Recurrent Cystitis: A Retrospective Case Series. Complement Med Res: 1–7.
103 Szöke H, Soldner G, Soldner U, Wolf U (2019) Behandlung unkomplizierter Infekte der unteren Harnwege (Urozystitis) aus Sicht der Anthroposophischen Medizin: Empfehlungen einer internationalen Expertengruppe für Ärzte, Pflegende und Therapeuten. Anthromedics. Available: https://www.anthromedics.org/PRA-0895-DE. Accessed 19 February 2020.
104 Soldner G, Stellmann H (2018) Individuelle Pädiatrie. Leibliche, seelische und geistige Aspekte in Diagnostik und Beratung. Anthroposophisch-homöopathische Therapie. Kap. Entzündungen der Harnwege. Stuttgart: Wissenschaftliche Verlagsgesellschaft. 390–411.
105 Karutz M, Soldner G, Soldner U, Gnatz B (2014) Einleitung/ Kamillendampfsitzbad. Merkurstab 67 (2): 148–150.
106 Lee BSB, Bhuta T, Simpson JM, Craig JC (2012) Methenamine hippurate for preventing urinary tract infections. Cochrane Database Syst Rev 10. Available: https://www.cochranelibrary.com/cdsr/doi/10.1002/14651858.CD003265.pub3/full. Accessed 10 November 2019.
107 Forbes R, Ali A, Abouhajar A, Brennand C, Brown H, et al. (2018) ALternatives To prophylactic Antibiotics for the treatment of Recurrent urinary tract infection in women (ALTAR): study protocol for a multicentre, pragmatic, patient-randomised, non-inferiority trial. Trials 19: 616.
108 Brumfitt W, Hamilton-Miller JM (1998) Efficacy and safety profile of long-term nitrofurantoin in urinary infections: 18 years’ experience. J Antimicrob Chemother 42: 363–371.
109 Rudenko N, Dorofeyev A (2005) Prevention of recurrent lower urinary tract infections by long-term administration of fosfomycin trometamol. Double blind, randomized, parallel group, placebo controlled study. Arzneimittelforschung 55: 420–427.
110 Huttner A, Verhaegh EM, Harbarth S, Muller AE, Theuretzbacher U, et al. (2015) Nitrofurantoin revisited: a systematic review and meta-analysis of controlled trials. J Antimicrob Chemother 70: 2456–2464.
111 Beerepoot MAJ, ter Riet G, Nys S, van der Wal WM, de Borgie CAJM, et al. (2011) Cranberries vs antibiotics to prevent urinary tract infections: a randomized double-blind noninferiority trial in premenopausal women. Arch Intern Med 171: 1270–1278.
Die vier wichtigsten Referenzen
6 Sihra N, Goodman A, Zakri R, Sahai A, Malde S. Nonantibiotic prevention and management of recurrent urinary tract infection. Nat Rev Urol. 2018;15:750.
7 Finucane TE. «Urinary Tract Infection»—Requiem for a Heavyweight. JAGS 65:1650–1655, 2017.
DOI: 10.1111/jgs.14907
70 Smith AL, Stapleton AE, Brown J, Wyman JF, Berry A, et al. Treatment and Prevention of Recurrent Lower Urinary Tract Infections in Women: A Rapid Review with Practice Recommendations. J Urol. 2018;200:1174–91.
71 Beerepoot M, Geerlings S.Non-Antibiotic Prophylaxis for Urinary Tract Infections. Pathogens. 2016;5:36.